NCT03770117
- Conditions
- Atrophy, Body Weight, Body Weight Changes, +13 more
- Locations
-
- Manchester University NHS Foundation Trust Manchester, Gtr Manchester, United Kingdom
Clinical trial condition
Pancreatic Ductal Adenocarcinoma
Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
181 public trials
74 recruiting studies
Pancreatic Ductal Adenocarcinoma trial results
Completed
IACS-010759 in Advanced Cancers
NCT03291938
- Conditions
- Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +46 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03794128
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +25 more
- Locations
-
- University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
- Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center New York, United States
- The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- Tennessee Oncology Nashville, Tennessee, United States
NCT02790944
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
NCT02981342
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Yale University School of Medicine New Haven, Connecticut, United States
- Illinois CancerCare Peoria, Illinois, United States
- Research Medical Center Kansas City, Missouri, United States
- Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
NCT03973736
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Locations
-
- Azienda USL - IRCCS di Reggio Emilia Reggio Emilia, Italy
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
- Locations
-
- Shaare Zedek Medical Center Jerusalem, Israel
- Hadassah Medical Organization Jerusalem, Israel
- Sheba Medical Center Ramat Gan, Israel
Completed
Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial
NCT02440958
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Locations
-
Not specified
NCT01280058
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
- Locations
-
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Montefiore Medical Center-Weiler Hospital The Bronx, New York, United States
- Montefiore Medical Center - Moses Campus The Bronx, New York, United States
NCT01658943
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
- Locations
-
- The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
- The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States